Express News | ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering

ReutersFeb 15 23:17 ET

ReShape Lifesciences Announces Pricing of Upsized $6.0 Million Public Offering

Reshape LifesciencesFeb 15 00:00 ET

Home Healthcare Inflation Is Stubbornly High -- WSJ

WSJFeb 12 12:30 ET

ReShape Lifesciences Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology

Reshape LifesciencesFeb 3 00:00 ET

Express News | ReShape Lifesciences: In Process of Responding to Comments From SEC Regarding Agreement With Vyome

ReutersJan 13 08:32 ET

Press Release: ReShape Lifesciences(R) Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys

Dow JonesJan 13 08:31 ET